Company Subsidiaries Kannaway® and HempMeds® to Exhibit at Expo and Company Subsidiaries to Feature Celebrity Spokespeople
SAN DIEGO, May 29, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that at the 5th Annual Cannabis World Congress and Business Expo (CWCBE), taking place in New York City from May 31-June 2, the company’s Chief Executive Officer Dr. Stuart Titus will speak on medical cannabis and cannabidiol (CBD) research on May 31. Medical Marijuana, Inc. subsidiary HempMeds® will also be showing retail-ready cannabis products and exhibiting its line of CBD hemp oil products at the Expo in booth #100.
“I am looking forward to the opportunity to spread education on cannabis and specifically CBD so that we can begin to clear up some misconceptions and further cannabis research,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “With the first-ever import permits for Real Scientific Hemp Oil™ (RSHO™) from the governments of Mexico, Brazil and Paraguay, there is clearly an expanding global market for hemp cannabidiol (CBD) products and we plan to continue to be leaders in the industry.”
Also attending the conference will be subsidiary Kannaway® spokesperson Christian “Nigerian Nightmare” Okoye. The Nigerian-American former football player was the all-time rushing leader for the Kansas City Chiefs’ after playing six seasons with the team. Nicknamed the “Nigerian Nightmare” for his powerful running style and ability to break tackles, Okoye earned two Pro Bowl appearances and three playoff appearances throughout his professional football career. Now retired, Okoye has partnered with Kannaway to speak up on how CBD helps him live a normal, healthy life without the assistance of opioids and how many athletes could benefit from it as well.
Joining Christian Okoye will be HempMeds® spokesperson and first female UFC fighter Liz Carmouche. Carmouche is the UFC’s first openly-gay fighter and the UFC’s most decorated ex-military fighter. In addition to training for her upcoming fight against Jennifer Maia on July 14, Liz is speaking up on how CBD helps her train harder and recover faster. Both Okoye and Carmouche will speak on an Athlete Patient Panel on June 2 at 10:00 a.m. in room #1A16.
Visitors who stop by the HempMeds and Kannaway ® booth can expect to learn more about the Company’s unique line of CBD hemp oil products, including its award-winning brands like Dixie Botanicals® and RSHO™.
Dr. Titus will be speaking about CBD on May 31 at 12:00 p.m. in room #1A11. He will also be speaking on a panel discussing “Investing in Publicly Traded Cannabis Companies” on June 1 at 2:00 p.m. in room #1A16.
For more information about the CWCBE, visit http://www.cwcbexpo.com/new-york/2018.
About HempMeds®
HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC PINK: MJNA) and the Company’s exclusive master distributor and contracted marketing company, handling sales and distribution.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
CONTACT:
Public Relations Contact:
Andrew Hard
Chief Executive Officer CMW Media
P. 858-264-6600
